General Information of Drug (ID: DMHQEA0)

Drug Name
Oltipraz
Synonyms
CB-1400; Oltipraz (mucositis/radiation sickness/cancer); Oltipraz (mucositis/radiation sickness/cancer), Canopus Biopharma; Syntheticdithiolethione (oral, acute radiation syndrome/mucositis/cancer), Canopus
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 3 [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C8H6N2S3
Canonical SMILES
CC1=C(SSC1=S)C2=NC=CN=C2
InChI
InChI=1S/C8H6N2S3/c1-5-7(12-13-8(5)11)6-4-9-2-3-10-6/h2-4H,1H3
InChIKey
CKNAQFVBEHDJQV-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
47318
ChEBI ID
CHEMBL178459
CAS Number
64224-21-1
UNII
6N510JUL1Y
DrugBank ID
DB12539
TTD ID
D0W4NM
Drug-Molecule Activity Atlas (DMA)NEW Click to Jump to the Detailed DMA Information of This Drug
Drug Pharmacogenomic Perturbation (DPP)NEW Click to Jump to the Detailed DPP Information of This Drug
Drug ADMET Endpoint Profile (DAE)NEW Click to Jump to the Detailed DAE Information of This Drug
Combinatorial Drugs (CBD) Click to Jump to the Detailed CBD Information of This Drug

References

1 ClinicalTrials.gov (NCT02068339) Efficacy and Safety of Oltipraz for Liver Fat Reduction in Patients With Non-Alcoholic Fatty Liver Disease Except for Liver Cirrhosis. U.S. National Institutes of Health.